BRIJ Medical celebrates oversubscription in seed round funding

BRIJ Medical announced completion of an over-subscribed $5.5M fundraising for further product development and commercial rollout of its incision and scar management system.

BRIJ Medical also unveiled its strategic rebrand from Brijjit Medical to BRIJ Medical. Today, BRIJ Medical is introducing new technologies designed to minimize wound complications and improve scar therapy. The round was led by Tim Gleeson (Vidant Capital) and an impressive list of MedTech industry veterans.

“As a surgeon, launching the new BRIJ Medical brand alongside a live surgery featuring our product was truly exciting,” said Felmont “Monte” Eaves, MD, founder and Chief Medical Officer at BRIJ Medical. “Our new brand reflects our commitment to excellence and innovation, and I look forward to the positive impact it will continue to have on physicians, clinical teams and, most importantly, patient outcomes.”

“If you want to use a product that will undoubtedly improve your patient’s life and your life, use Brijjit,” said Dr Wall. “The best inventions are simple and cost effective. Brijjit is both. This little device has had a huge impact on my practice.”

“In what is one of the most difficult fundraising environments I have seen in recent history, it is incredibly exciting to see how much interest is coming off the sidelines to participate in BRIJ’s seed fundraising. This is a testament to the team, the product, and Monte’s pioneering thought leadership”, said Tim Gleeson of VIDANT Capital.
MB Bureau